A

Active Director Director DIN 10192565
DIN 10192565 First appointment Jun 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Aysha

Data last updated:

Aysha is a Director at Neorangic Healthcare Private Limited (since 2023). The company operates in Chemicals. Neorangic Healthcare Private Limited reported revenue of ₹1.34 Cr (FY 2025).

DIN 10192565
Primary Designation Director
Industry Chemicals
First Appointment 06 Jun 2023
Oldest Company Age 5 yrs
Largest company Neorangic Healthcare Private Limited · ₹1.34 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neorangic Healthcare Private Limited U24230CH2021PTC043900
Director06 Jun 20232021₹1.34 Cr (FY 2025)Active

Board colleagues of Aysha

NameDINCompanyDesignation
Farman Khan10552389Neorangic Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neorangic Healthcare Private Limited
Premium access

Shareholding and investment profile for Aysha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aysha

Aysha currently holds 1 directorship: Neorangic Healthcare Private Limited (Director, since 06 Jun 2023, revenue ₹1.34 Cr (FY 2025)).

Aysha was first appointed on 06 Jun 2023 as Director at Neorangic Healthcare Private Limited.

The current boards of Aysha's companies include Farman Khan (Neorangic Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available